10mg

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a membrane-anchored, mucin-type glycoprotein present in malignant cells. It is used as tumor marker to monitor breast cancer treatment and disease recurrence.

Carbohydrate
antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be
elevated in many types of gastrointestinal cancer, such as colorectal cancer,
esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of
pancreatic cancer

Carbohydrate
antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be
elevated in many types of gastrointestinal cancer, such as colorectal cancer,
esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of pancreatic cancer

CA242, known as carbohydrate antigen 242, is a sialyated carbohydrate antigen. It is a cancer-associated glycoprotein expressed in the sera of pancreatic cancer patients. CA242 is a useful biomarker for the diagnosis, prognosis, and surveillance of gastrointestinal malignancies.

CA242, known as carbohydrate antigen 242, is a sialyated carbohydrate antigen. It is a cancer-associated glycoprotein expressed in the sera of pancreatic cancer patients. CA242 is a useful biomarker for the diagnosis, prognosis, and surveillance of gastrointestinal malignancies.

CA72-4 (Cancer antigen 72-4), also known as Tumor associated glycoprotein (TAG) 72, is a mucin-like protein of high molecular weight (200- 400 kD). CA 72-4 has high specificity for diagnosis of benign diseases. It is also a helpful marker in the diagnosis of gastric cancer, ovarian carcinoma and colorectal carcinoma.

CA72-4 (Cancer antigen 72-4), also known as Tumor associated glycoprotein (TAG) 72, is a mucin-like protein of high molecular weight (200- 400 kD). CA 72-4 has high specificity for diagnosis of benign diseases. It is also a helpful marker in the diagnosis of gastric cancer, ovarian carcinoma and colorectal carcinoma.

CA72-4 (Cancer antigen 72-4), also known as Tumor associated glycoprotein (TAG) 72, is a mucin-like protein of high molecular weight (200- 400 kD). CA 72-4 has high specificity for diagnosis of benign diseases. It is also a helpful marker in the diagnosis of gastric cancer, ovarian carcinoma and colorectal carcinoma.

PCT, a 116 amino acid (aa) protein, is comprised of three sections including a 57 aa N-terminal PCT, a 32 aa calcitonin and a 21 aa katacalcin. Calcitonin is a hormone, derived from PCT cleavage. PCT is a good diagnosis marker for bacterial infection. Other diseases such as sepsis, inflammation, surgery, heat shock, burn injuries and cardiogenic shock can also cause an increase of PCT level in blood.

PCT is a 116 amino acid (aa) protein. It is comprised of three sections of a 57 aa N-terminal PCT, a 32 aa calcitonin and a 21 aa katacalcin. Calcitonin is a hormone, derived from PCT cleavage. PCT is a good diagnosis marker for bacterial infection. Other diseases such as sepsis, inflammation, surgery, heat shock, burn injuries and cardiogenic shock can also cause an increase of PCT level in blood.

Cardiac
TnT (cTnT) is the largest subunit of the troponin complex which is composed of
cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with
a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful
biomarker for the diagnosis of acute myocardial infarction.

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Cardiac
TnT (cTnT) is the largest subunit of the troponin complex which is composed of
cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with
a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful
biomarker for the diagnosis of acute myocardial infarction.

Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.

Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.

Creatine kinase (CK) is a dimeric enzyme, including three isoforms of creatine kinase: BB, MM, and MB. Level of serum CK-MB will be increased within 4-6 hours after a myocardial infarction (MI). CK-MB is considered as a useful marker for the diagnosis of myocardial infarction.

Creatine kinase (CK) is a dimeric enzyme, including three isoforms of creatine kinase: BB, MM, and MB. Level of serum CK-MB will be increased within 4-6 hours after a myocardial infarction (MI). CK-MB is considered as a useful marker for the diagnosis of myocardial infarction.

Creatine kinase (CK) is a dimeric enzyme, including three isoforms of creatine kinase: BB, MM, and MB. Level of serum CK-MB will be increased within 4-6 hours after a myocardial infarction (MI). CK-MB is considered as a useful marker for the diagnosis of myocardial infarction.

Creatine kinase (CK) is a dimeric enzyme, including three isoforms of creatine kinase: BB, MM, and MB. Level of serum CK-MB will be increased within 4-6 hours after a myocardial infarction (MI). CK-MB is considered as a useful marker for the diagnosis of myocardial infarction.

C-reactive protein (CRP) is synthesized in the liver by macrophage. Its level in blood increases when inflammation occurs. CRP serves as a useful marker for diagnosis of inflammation. High-sensitivity C-reactive protein (hsCRP), can serve as a risk marker for the diagnosis of myocardial infarction, ischemic stroke, peripheral vascular disease. Measuring hsCRP in blood is helpful to provide positive treatment of the disease.

C-reactive protein (CRP) is synthesized in the liver by macrophage. Its level in blood increases when inflammation occurs. CRP serves as a useful marker for diagnosis of inflammation. High-sensitivity C-reactive protein (hsCRP), can serve as a risk marker for the diagnosis of myocardial infarction, ischemic stroke, peripheral vascular disease. Measuring hsCRP in blood is helpful to provide positive treatment of the disease.

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Cytidine 5′-Diphosphate Trisodium Salt, Hydrate

D-dimer known as a fibrin degradation product, is presented in blood after a blood clot is degraded by fibrinolysis. Its concentration in blood increases when deep venous thrombosis (DVT), pulmonary embolism (PE) or disseminated intravascular coagulation (DIC) happens. It serves as a useful maker for the diagnosis of these diseases.

D-dimer known as a fibrin degradation product, is presented in blood after a blood clot is degraded by fibrinolysis. Its concentration in blood increases when deep venous thrombosis (DVT), pulmonary embolism (PE) or disseminated intravascular coagulation (DIC) happens. It serves as a useful maker for the diagnosis of these diseases.

D-dimer known as a fibrin degradation product, is presented in blood after a blood clot is degraded by fibrinolysis. Its concentration in blood increases when deep venous thrombosis (DVT), pulmonary embolism (PE) or disseminated intravascular coagulation (DIC) happens. It serves as a useful maker for the diagnosis of these diseases.

D-dimer known as a fibrin degradation product, is presented in blood after a blood clot is degraded by fibrinolysis. Its concentration in blood increases when deep venous thrombosis (DVT), pulmonary embolism (PE) or disseminated intravascular coagulation (DIC) happens. It serves as a useful maker for the diagnosis of these diseases.

Deoxyribonuclease I, From Bovine Pancreas, Lyophilized Powder